123 related articles for article (PubMed ID: 10635995)
21. DNA sequence analysis of interlocus recombination between the human T-cell receptor gamma variable (GV) and beta diversity-joining (BD/BJ) sequences on chromosome 7 (inversion 7).
Ballinger SW; Judice SA; Nicklas JA; Albertini RJ; O'Neill JP
Environ Mol Mutagen; 2002; 40(2):85-92. PubMed ID: 12203400
[TBL] [Abstract][Full Text] [Related]
22. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
Messier TL; O'Neill JP; Finette BA
Hum Mutat; 2006 Aug; 27(8):829. PubMed ID: 16835902
[TBL] [Abstract][Full Text] [Related]
23. Use of inverse PCR to amplify and sequence breakpoints of HPRT deletion and translocation mutations.
Williams M; Rainville IR; Nicklas JA
Environ Mol Mutagen; 2002; 39(1):22-32. PubMed ID: 11813293
[TBL] [Abstract][Full Text] [Related]
24. Alternative end-joining in follicular lymphomas' t(14;18) translocation.
Marculescu R; Le T; Böcskör S; Mitterbauer G; Chott A; Mannhalter C; Jaeger U; Nadel B
Leukemia; 2002 Jan; 16(1):120-6. PubMed ID: 11840271
[TBL] [Abstract][Full Text] [Related]
25. Sequence analysis of deletion mutations at the HPRT locus of human T-lymphocytes: association of a palindromic structure with a breakpoint cluster in exon 2.
Osterholm AM; Bastlová T; Meijer A; Podlutsky A; Zanesi N; Hou SM
Mutagenesis; 1996 Sep; 11(5):511-7. PubMed ID: 8921514
[TBL] [Abstract][Full Text] [Related]
26. Spectrum of in vivo hprt mutations in T lymphocytes from atomic bomb survivors. I. Sequence alterations in cDNA.
Shimahara H; Kato T; Hirai Y; Akiyama M
Carcinogenesis; 1995 Mar; 16(3):583-91. PubMed ID: 7697817
[TBL] [Abstract][Full Text] [Related]
27. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.
Finette BA
DNA Repair (Amst); 2006 Sep; 5(9-10):1049-64. PubMed ID: 16807138
[TBL] [Abstract][Full Text] [Related]
28. In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.
Messier TL; O'Neill JP; Hou SM; Nicklas JA; Finette BA
EMBO J; 2003 Mar; 22(6):1381-8. PubMed ID: 12628930
[TBL] [Abstract][Full Text] [Related]
29. HPRT mutations in vivo in human CD 34+ hematopoietic stem cells.
Grant BW; Trombley LM; Hunter TC; Nicklas JA; O'Neill JP; Albertini RJ
Mutat Res; 1999 Dec; 431(2):183-98. PubMed ID: 10635986
[TBL] [Abstract][Full Text] [Related]
30. Analysis of X-ray-induced HPRT mutations in CHO cells: insertion and deletions.
Fuscoe JC; Zimmerman LJ; Fekete A; Setzer RW; Rossiter BJ
Mutat Res; 1992 Oct; 269(2):171-83. PubMed ID: 1383700
[TBL] [Abstract][Full Text] [Related]
31. Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane.
Steen AM; Meyer KG; Recio L
Mutagenesis; 1997 Mar; 12(2):61-7. PubMed ID: 9106245
[TBL] [Abstract][Full Text] [Related]
32. Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic lacI gene of Big Blue rats.
Chen T; Aidoo A; Manjanatha MG; Mittelstaedt RA; Shelton SD; Lyn-Cook LE; Casciano DA; Heflich RH
Mutat Res; 1998 Jul; 403(1-2):199-214. PubMed ID: 9726020
[TBL] [Abstract][Full Text] [Related]
33. Large deletions are tolerated at the hprt locus of in vivo derived human T-lymphocytes.
Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Moore MM
Mutat Res; 1992 Dec; 283(4):255-62. PubMed ID: 1383798
[TBL] [Abstract][Full Text] [Related]
34. Influence of smoking and donor age on the spectrum of in vivo mutation at the HPRT-locus in T lymphocytes of healthy adults.
Podlutsky A; Hou SM; Nyberg F; Pershagen G; Lambert B
Mutat Res; 1999 Dec; 431(2):325-39. PubMed ID: 10635998
[TBL] [Abstract][Full Text] [Related]
35. Molecular description of three macro-deletions and an Alu-Alu recombination-mediated duplication in the HPRT gene in four patients with Lesch-Nyhan disease.
Brooks EM; Branda RF; Nicklas JA; O'Neill JP
Mutat Res; 2001 May; 476(1-2):43-54. PubMed ID: 11336982
[TBL] [Abstract][Full Text] [Related]
36. Deletion mutations in the hprt gene of T-lymphocytes as a biomarker for genomic rearrangements important in human cancers.
Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Moore MM
Carcinogenesis; 1994 Jul; 15(7):1463-6. PubMed ID: 8033326
[TBL] [Abstract][Full Text] [Related]
37. A mouse model for the study of in vivo mutational spectra: sequence specificity of ethylene oxide at the hprt locus.
Walker VE; Skopek TR
Mutat Res; 1993 Jul; 288(1):151-62. PubMed ID: 7686258
[TBL] [Abstract][Full Text] [Related]
38. A new T-lymphocyte cloning assay for detection of in vivo mutations in the human hypoxanthine-guanine phosphoribosyltransferase gene.
Uematsu K; Yasuda J; Sekine T; Sugano K; Kudoh S; Sekiya T
Environ Mol Mutagen; 1997; 30(1):31-9. PubMed ID: 9258327
[TBL] [Abstract][Full Text] [Related]
39. Characterization of mutations in phenotypic variants of hypoxanthine phosphoribosyltransferase deficiency.
Sege-Peterson K; Chambers J; Page T; Jones OW; Nyhan WL
Hum Mol Genet; 1992 Sep; 1(6):427-32. PubMed ID: 1301916
[TBL] [Abstract][Full Text] [Related]
40. DNA sequence analysis of in vivo hprt mutation in human T lymphocytes.
Recio L; Cochrane J; Simpson D; Skopek TR; O'Neill JP; Nicklas JA; Albertini RJ
Mutagenesis; 1990 Sep; 5(5):505-10. PubMed ID: 2263208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
